Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,773 | 187 | 55.3% |
| Travel and Lodging | $3,801 | 9 | 44.1% |
| Education | $54.43 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $3,426 | 26 | $0 (2023) |
| Medtronic USA, Inc. | $2,015 | 14 | $0 (2019) |
| Boston Scientific Corporation | $794.62 | 43 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $287.36 | 19 | $0 (2024) |
| ABBVIE INC. | $248.31 | 15 | $0 (2024) |
| Medtronic, Inc. | $218.08 | 13 | $0 (2024) |
| Saluda Medical Americas, Inc. | $217.55 | 6 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $151.74 | 8 | $0 (2024) |
| Abbott Laboratories | $113.43 | 6 | $0 (2023) |
| Stimwave Technologies Incorporated | $101.91 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $892.35 | 40 | Boston Scientific Corporation ($243.60) |
| 2023 | $1,222 | 67 | Boston Scientific Corporation ($516.57) |
| 2022 | $703.38 | 40 | ABBVIE INC. ($117.80) |
| 2021 | $77.67 | 4 | Nevro Corp. ($23.07) |
| 2019 | $3,868 | 37 | Medtronic USA, Inc. ($2,015) |
| 2018 | $1,717 | 8 | Nevro Corp. ($1,645) |
| 2017 | $148.47 | 3 | Nevro Corp. ($128.30) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $102.96 | General |
| Category: General - Therapies_NMD | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: PAIN | ||||||
| 11/07/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.98 | General |
| 10/31/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.34 | General |
| Category: Opioid Analgesic | ||||||
| 10/28/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/19/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Education | In-kind items and services | $22.34 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Musculoskeletal | ||||||
| 09/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $50.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $45.26 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $43.57 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/23/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 08/19/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Opioid Analgesic | ||||||
| 07/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/20/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/14/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/09/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 05/09/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Education | In-kind items and services | $16.43 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/03/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Musculoskeletal | ||||||
| 04/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 836 | 1,255 | $878,378 | $98,697 |
| 2022 | 17 | 620 | 780 | $650,539 | $63,205 |
| 2021 | 7 | 302 | 362 | $270,935 | $19,386 |
| 2020 | 3 | 898 | 1,214 | $1.0M | $65,881 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 434 | $202,744 | $32,150 | 15.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 74 | 77 | $34,573 | $14,997 | 43.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 54 | 54 | $19,116 | $8,287 | 43.4% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 112 | 132 | $47,124 | $7,952 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 105 | $33,156 | $4,937 | 14.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 52 | 117 | $100,100 | $4,845 | 4.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $33,110 | $4,235 | 12.8% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Office | 2023 | 14 | 16 | $46,288 | $3,808 | 8.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 16 | 26 | $77,805 | $3,159 | 4.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $14,345 | $2,751 | 19.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 12 | 12 | $35,859 | $2,382 | 6.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 22 | 26 | $69,394 | $2,373 | 3.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 16 | 26 | $40,679 | $1,792 | 4.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 15 | 18 | $35,961 | $1,726 | 4.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 11 | 17 | $26,498 | $1,185 | 4.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 12 | 12 | $25,449 | $735.33 | 2.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 15 | $14,835 | $536.12 | 3.6% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 18 | 22 | $16,940 | $411.20 | 2.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 18 | 20 | $3,100 | $188.00 | 6.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 43 | $860.00 | $146.20 | 17.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 17 | $442.00 | $102.67 | 23.2% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 42 | 43 | $19,307 | $8,433 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 119 | $58,636 | $8,222 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 155 | $51,529 | $7,958 | 15.4% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Office | 2022 | 16 | 22 | $63,646 | $5,100 | 8.0% |
About Dr. Leigh Stevens, MD
Dr. Leigh Stevens, MD is a Pain Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1558358770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leigh Stevens, MD has received a total of $8,628 in payments from pharmaceutical and medical device companies, with $892.35 received in 2024. These payments were reported across 199 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,773).
As a Medicare-enrolled provider, Stevens has provided services to 2,656 Medicare beneficiaries, totaling 3,611 services with total Medicare billing of $247,169. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Pain Medicine
- Location Hickory, NC
- Active Since 10/03/2005
- Last Updated 01/20/2025
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1558358770
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $3,373
- KYPHON Balloon Kyphoplasty (Device) $1,806
- XTAMPZA (Drug) $249.93
- Evoke (Device) $217.55
- BOTOX (Biological) $204.84
- OSTEOCOOL RF ABLATION (Device) $196.36
- WaveWriter Alpha Prime 16 (Device) $161.86
- Xeomin (Biological) $151.74
- INTELLIS ADAPTIVESTIM (Device) $137.75
- QSYMIA (Drug) $97.14
- Superion ISS (Device) $96.69
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $93.44
- Qutenza (Drug) $74.82
- PROCLAIM (Device) $67.20
- mild Device Kit (Device) $60.30
- PAINTEQ (Device) $58.52
- SPRINT PNS System (Device) $56.58
- Saxenda (Drug) $50.44
- QULIPTA (Drug) $50.16
- UBRELVY (Drug) $41.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.